Sellas Life Sciences Surges 15% on Retail Buzz
June 11, 2026·about 1 hour ago·via Stocktwits
Sellas Life Sciences is drawing heavy retail attention as traders focus on a possible REGAL Phase 3 catalyst. The stock jumps 15% as momentum builds around the biotech name. Investors are watching closely for updates that could move the shares again. The market reaction shows how quickly speculation can fuel trading in a hot biotech setup. Read more about this...